Leonard S. Jacob
Chairman at Life Science Advisors LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Marvin Samson | M | 82 |
University of the Sciences in Philadelphia
| 8 years |
Martin Rose | M | - |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | 25 years |
Nicole LaBrosse | F | 41 | 2 years | |
Nancy McNutt | F | - |
University of the Sciences in Philadelphia
| - |
Rebecca Powers | F | - |
University of the Sciences in Philadelphia
| - |
John Negrey | M | - |
Temple University School of Medicine
| - |
Daniel Dries | M | - |
Temple University School of Medicine
| - |
Paul Weidner | M | - |
Temple University School of Medicine
| - |
Lucien Trigiano | M | - |
Temple University School of Medicine
| - |
Karen Starko | F | - |
Temple University School of Medicine
| - |
Frederick Simeone | M | - |
Temple University School of Medicine
| - |
Elliot Menkowitz | M | - |
Temple University School of Medicine
| - |
Paul Hermany | M | - |
Temple University School of Medicine
| - |
Sandra Harmon-Weiss | F | - |
Temple University School of Medicine
| - |
Gerald Lemole | M | - |
Temple University School of Medicine
| - |
Thomas Bergmann | M | - |
QuiqMeds, Inc.
QuiqMeds, Inc. Packaged SoftwareTechnology Services QuiqMeds, Inc. provides a cloud based enterprise platform that is intended to work across health systems and their components such as hospital emergency departments, urgent care centers, medical centers, workplace health clinics, and group practices. The company is headquartered in Malvern, PA. | - |
Lawrence Jay Kessel | M | - |
QuiqMeds, Inc.
QuiqMeds, Inc. Packaged SoftwareTechnology Services QuiqMeds, Inc. provides a cloud based enterprise platform that is intended to work across health systems and their components such as hospital emergency departments, urgent care centers, medical centers, workplace health clinics, and group practices. The company is headquartered in Malvern, PA. | 18 years |
Helen Torley | M | 61 | 2 years | |
Pascale Nini | M | - |
QuiqMeds, Inc.
QuiqMeds, Inc. Packaged SoftwareTechnology Services QuiqMeds, Inc. provides a cloud based enterprise platform that is intended to work across health systems and their components such as hospital emergency departments, urgent care centers, medical centers, workplace health clinics, and group practices. The company is headquartered in Malvern, PA. | - |
Richard G. Stefanacci | M | - |
University of the Sciences in Philadelphia
| - |
Catherine Sohn | M | 71 |
University of the Sciences in Philadelphia
| - |
Don Daddario | M | - |
University of the Sciences in Philadelphia
| - |
Kevin Mayo | M | - |
University of the Sciences in Philadelphia
| - |
Gene Salkind | M | 71 |
Temple University School of Medicine
| - |
Kent E. Lieginger | M | 72 |
University of the Sciences in Philadelphia
| 11 years |
Robyn G. Karlstadt | M | - |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | 20 years |
Michael S. Hunt | M | 77 |
Life Science Advisors LLC
| 27 years |
Randal Betz | M | 72 |
Temple University School of Medicine
| - |
Andrew J. Ferrara | M | 84 |
University of the Sciences in Philadelphia
| - |
Phil Gerbino | M | 76 |
University of the Sciences in Philadelphia
| 29 years |
Pamela Ramanathan | F | - |
University of the Sciences in Philadelphia
| - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Robert F. Apple | M | 58 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA.
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 27 years |
Eamonn Hobbs | M | 65 | 7 years | |
Peter J. Graham | M | 57 | 7 years | |
Jacques Gonella | M | 82 | 18 years | |
Paul Wotton | M | 63 | 10 years | |
Jack Stover | M | 69 | 4 years | |
Michael Zasloff | M | 78 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 9 years |
Kaushik J. Dave | M | 63 | 5 years | |
Jennifer Stacey | F | 59 | 1 years | |
Peter Greenleaf | M | 54 | 4 years | |
John J. Howarth | M | - | 8 years | |
Robert P. Roche | M | 68 | 9 years | |
Edward F. Kessig | M | - | 4 years | |
Jonathan S. Jaffe | M | - | 9 years | |
Tram Bui | F | - | 2 years | |
Anton G. Gueth | M | 67 | 19 years | |
Karen Smith | M | 56 | 3 years | |
Keith Muckenhirn | M | 61 | 15 years | |
Thomas J. Garrity | M | 75 | 19 years | |
Dean H. Taylor | M | - |
Smithkline & French Laboratories US, Inc.
| 10 years |
Amy Welsh | F | 53 | 3 years | |
Robert Chen | M | - |
Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | 9 years |
Carmen Volkart | F | 63 | 1 years | |
Edward Tykot | M | - | 3 years | |
Pavan Handa | M | - | - | |
William Kinney | M | 66 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 6 years |
Thomas Malefyt | M | - |
Smithkline & French Laboratories US, Inc.
| - |
Dan Kelsey | M | - | - | |
Bruce Ganem | M | - |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 2 years |
Patrick Michael Shea | M | 59 | 1 years | |
Greg DeFilippis | M | - | 6 years | |
James Tursi | M | 59 | 2 years | |
Patrick Madsen | M | - | 5 years | |
Susan Thornton | F | - | - | |
Bruce Freundlich | M | - | - | |
John Hayes | M | - | - | |
Stanley Crooke | M | 78 |
Smithkline & French Laboratories US, Inc.
| 9 years |
Peter Richardson | M | 64 | 1 years | |
John R. Leone | M | 77 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | - |
Thomas Peter Stagnaro | M | 81 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | - |
William Joseph Murphy | M | 80 |
Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | 2 years |
Steven B. Ratoff | M | 81 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | 7 years |
J. Robert LeShufy | M | 102 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | - |
William Harral | M | 84 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | 1 years |
Robert A. Vukovich | M | - |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | - |
Seth W. Hamot | M | 61 |
Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | 2 years |
Robert G. L. Shorr | M | 71 |
Smithkline & French Laboratories US, Inc.
| 6 years |
C. Ralph Daniel | M | - |
Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | 3 years |
Dario N. R. Carrara | M | 60 | 15 years | |
H. LeRoux Jooste | M | 68 | - | |
Brian Dickson | M | - |
Smithkline & French Laboratories US, Inc.
| 9 years |
James Fickenscher | M | 60 | 2 years | |
Fred M. Powell | M | 63 | 6 years | |
Richard Bagley | M | 80 |
Smithkline & French Laboratories US, Inc.
| 17 years |
Douglas E. Linton | M | 76 |
Bradley Pharmaceuticals, Inc.
Bradley Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Bradley Pharmaceuticals, Inc. is a specialty pharmaceutical company, engages in the acquisition, development and marketing of prescription and products to physician specialties in the United States and international markets. The company has two divisions: Doak Dermatologics and Kenwood Therapeutics. The Doak Dermatologics division promotes branded dermatologic and podiatric products including ADOXA, KERALAC, SOLARAZE, ZODERM, LIDAMANTLE, ROSULA, SELSEB and ZONALON to dermatologists and podiatrists. The Kenwood Therapeutics division offers branded gastrointestinal products including ANAMANTLE HC, PAMINE and PAMINE FORTE to gastroenterologists, colon and rectal surgeons. It also markets nutritional supplements and respiratory products including FLORA-Q. The company’s products are used in the treatment of acne, mild to severe dry skin and nail disorders, actinic keratoses, precancerous skin lesions, topical anesthetic and anti-inflammatory diseases, dandruff, hemorrhoids and anal fissures. It markets and sells it's products through sales personnel and wholesalers. The company was founded by Daniel Glassman in 1985 and is headquartered in Fairfield, NJ. | 2 years |
David H. Bergstrom | M | 70 | - | |
James Cavanaugh | M | 87 |
Smithkline & French Laboratories US, Inc.
| 4 years |
Sidney M. Hecht | M | 80 |
Smithkline & French Laboratories US, Inc.
| 6 years |
David J. Ecker | M | 69 |
Smithkline & French Laboratories US, Inc.
| 5 years |
Edward Smith | M | 53 |
InKine Pharmaceutical Co., Inc.
InKine Pharmaceutical Co., Inc. Pharmaceuticals: MajorHealth Technology Inkine Pharmaceutical Co., Inc. develops pharmaceutical products. The firm's products include Visicol(R) and IBStat(R). Its products are used for diagnosis and treatment of gastrointestinal disorders. The company was founded by Leonard S. Jacob in 1970 and is headquartered in Blue Bell, PA. | 5 years |
Zola P. Horovitz | M | 89 |
Genaera Corp.
Genaera Corp. Pharmaceuticals: MajorHealth Technology Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA. | 14 years |
Claude E. Richardson | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 93 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Leonard S. Jacob
- Personal Network